Access cutting-edge multifocal motor neuropathy treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access multifocal motor neuropathy specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multifocal motor neuropathy treatment provided free
The purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of DNTH103 in participants with multifocal motor neuropathy (MMN).
Sponsor: Dianthus Therapeutics
Check if you qualify for this multifocal motor neuropathy clinical trial in Kansas City, KS
If you're searching for multifocal motor neuropathy treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multifocal motor neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.